Remove Compliance Remove COVID-19 Remove Fraud Remove Informed Consent
article thumbnail

Introduction to Telebehavioral Health

AIHC

Compliance Considerations for Best Outcomes Written in collaboration with the AIHC Volunteer Education Committee Delivering mental health services via telehealth has increased since the COVID-19 pandemic. Higher rates of use of telehealth are now standard in many practices since the coronavirus disease 2019 (COVID-19) pandemic.

article thumbnail

Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials

Hall Render

This draft guidance expands on previous FDA recommendations released in the midst of the COVID-19 pandemic. For health care institutions conducting DCTs, considerations include compliance with fraud and abuse and beneficiary inducement requirements.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 23: The Emerging Investigatory Focus on Telehealth: What You Need to Know

Healthcare Law Today

He advises entrepreneurial health care providers and technology companies on business arrangements, compliance, and corporate matters in telemedicine, digital health, remote patient monitoring, and click-and-mortar services. I’m currently Deputy General Counsel of LifeMD, a growing telemedicine company.

article thumbnail

AI in Healthcare

HIPAA Journal

AI is used by the finance industry to detect potential credit card fraud. Drug development processes can be significantly accelerated with AI technologies that quickly extract meaningful information from large datasets to predict harmful interactions with existing drugs, improve the quality of clinical trials, and reduce time to approval.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Plaintiff knew about it, too, since he signed an informed consent document mentioning it. Negligence requires an evaluation of a defendant’s reasonableness, and all relevant NC authority includes relevant regulatory compliance in that mix. 4th 696 (3d.

FDA 105